Sumatriptan, a 5HT1 receptor agonist administered by the subcutaneous route, causes a vasopressor response in the systemic and pulmonary arterial circulations and coronary artery vasoconstriction.
No takes yet. Share an insight, caveat, or question.
MacIntyre et al. (1993) studied this question.